Navlimetostat, CAS [[2630904-45-7]]

Produktübersicht

• Artikelname: Navlimetostat, CAS [[2630904-45-7]]
• Artikelnummer: MCE-HY-139611
• Hersteller Artikelnummer: HY-139611
• Alternativnummer: MCE-HY-139611-10MMX1ML,MCE-HY-139611-25MG,MCE-HY-139611-100MG,MCE-HY-139611-50MG,MCE-HY-139611-1MG,MCE-HY-139611-5MG,MCE-HY-139611-10MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: MRTX-1719, BMS-986504

Produktbeschreibung

Navlimetostat is a potent, orally active, selective PRMT5-MTA complex inhibitor, with IC50 of 3.6 and 20.5 nM for PRMT5-MTA and PRMT5. Navlimetostat binds to the PRMT5-MTA complex, with KD value of 0.14 pM. Navlimetostat shows antineoplastic activity in vitro and in vivo, and can be used for cancer study[1][2].

Produkteigenschaften

• Molekulargewicht: 464.88
• Reinheit: 99.28
• CAS Nummer: [2630904-45-7]
• Formel: C23H18ClFN6O2
• Target-Kategorie: Histone Methyltransferase

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound